Supplementary Table 1
收藏Mendeley Data2026-04-18 收录
官方服务:
资源简介:
Supplementary Table 1 for Kang & Nabel Smith et al. (JAAD, 2025). "Infection risk of rituximab monotherapy versus combination therapy with rituximab and mycophenolic acid in systemic sclerosis"
Kang、Nabel Smith等学者于2025年发表于《美国皮肤病学会杂志(Journal of the American Academy of Dermatology)》的研究《系统性硬化症中利妥昔单抗单药治疗与利妥昔单抗联合麦考酚酸治疗的感染风险》的补充表1
创建时间:
2025-01-20




